Percutaneous bone marrow transplantation using fractional ablative Erbium: YAG laser

Luis Rodriguez-Menocal; Marcela Salgado; Stephen C Davis; Jill Waibel; Arsalan Shabbir; Audrey Cox; Evangelos V Badiavas

doi:10.1371/journal.pone.0093004

Percutaneous bone marrow transplantation using fractional ablative Erbium: YAG laser

Luis Rodriguez-Menocal, Marcela Salgado, Stephen C Davis, Jill Waibel, Arsalan Shabbir, Audrey Cox, Evangelos V Badiavas

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Plos One
Volume	9
DOIs	https://doi.org/10.1371/journal.pone.0093004
State	Published - Mar 25 2014
Externally published	Yes

Disciplines

Pathology

Access to Document

10.1371/journal.pone.0093004License: Unspecified

Cite this

@article{0733e1337eaf4936aea2a202e3dd3712,

title = "Percutaneous bone marrow transplantation using fractional ablative Erbium: YAG laser",

author = "Luis Rodriguez-Menocal and Marcela Salgado and Davis, \{Stephen C\} and Jill Waibel and Arsalan Shabbir and Audrey Cox and Badiavas, \{Evangelos V\}",

note = "Stem cell based therapies have the potential to address many disorders that currently have few if any therapeutic alternatives [1]-[3]. There are nevertheless special considerations that must be taken into account when considering cell-based therapeutics. Cells have several distinct properties that differ significantly from traditional agents such as their relatively large size and their rather fragile nature.",

year = "2014",

month = mar,

day = "25",

doi = "10.1371/journal.pone.0093004",

language = "American English",

volume = "9",

journal = "Plos One",

}

TY - JOUR

T1 - Percutaneous bone marrow transplantation using fractional ablative Erbium: YAG laser

AU - Rodriguez-Menocal, Luis

AU - Salgado, Marcela

AU - Davis, Stephen C

AU - Waibel, Jill

AU - Shabbir, Arsalan

AU - Cox, Audrey

AU - Badiavas, Evangelos V

N1 - Stem cell based therapies have the potential to address many disorders that currently have few if any therapeutic alternatives [1]-[3]. There are nevertheless special considerations that must be taken into account when considering cell-based therapeutics. Cells have several distinct properties that differ significantly from traditional agents such as their relatively large size and their rather fragile nature.

PY - 2014/3/25

Y1 - 2014/3/25

UR - http://europepmc.org/articles/PMC3965514

U2 - 10.1371/journal.pone.0093004

DO - 10.1371/journal.pone.0093004

M3 - Article

VL - 9

JO - Plos One

JF - Plos One

ER -

Percutaneous bone marrow transplantation using fractional ablative Erbium: YAG laser

Disciplines

Access to Document

Other files and links

Cite this